Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly teer » significantly better (Expand Search), significantly weaker (Expand Search), significantly lower (Expand Search)
decrease occur » decrease occurs (Expand Search), decrease accuracy (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 161 - 180 results of 5,105 for search '(( significantly teer decrease ) OR ( significant decrease occur ))', query time: 0.34s Refine Results
  1. 161
    Changes in the mean logMAR BCVA ± standard error from baseline to 6 months after IOI occurred.

    Changes in the mean logMAR BCVA ± standard error from baseline to 6 months after IOI occurred. by Kazushi Hirono (17867141)

    Published 2024
    “…<p>The mean logMAR BCVA when IOI occurred decreased significantly compared with before IOI occurred (<i>P</i> = 0.02). …”
    Save to List
    Saved in:
  2. 162
    Pathway analysis of significantly changed proteins comparing large stones vs sand.

    Pathway analysis of significantly changed proteins comparing large stones vs sand. by Jacob Rose (12981890)

    Published 2022
    Save to List
    Saved in:
  3. 163
    CONSORT flow diagram of participant recruitment and intervention.

    CONSORT flow diagram of participant recruitment and intervention. by Majid Ramezani (5477999)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 164
    Physical activity and dietary intake of the participants before and after the intervention.

    Physical activity and dietary intake of the participants before and after the intervention. by Majid Ramezani (5477999)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 165
    Comparison of the areas of quality of life before and after the intervention in synbiotic and placebo groups.

    Comparison of the areas of quality of life before and after the intervention in synbiotic and placebo groups. by Majid Ramezani (5477999)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 166
    Primary and secondary outcomes before and after the intervention in synbiotic and placebo groups.

    Primary and secondary outcomes before and after the intervention in synbiotic and placebo groups. by Majid Ramezani (5477999)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 167
    Comparison of baseline characteristics of the participants.

    Comparison of baseline characteristics of the participants. by Majid Ramezani (5477999)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 168
    Differences in population distribution between MediScope® and the actual population in Japan.

    Differences in population distribution between MediScope® and the actual population in Japan. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 169
    Switching patterns of ICS/LABA.

    Switching patterns of ICS/LABA. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 170
    Factors associated with exacerbations.

    Factors associated with exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 171
    Definition of each exacerbation.

    Definition of each exacerbation. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 172
    Definitions of treatment step classification.

    Definitions of treatment step classification. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 173
    Sensitivity analyses of breakthrough exacerbations.

    Sensitivity analyses of breakthrough exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 174
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 175
    Data for primary and sensitivity analysis.

    Data for primary and sensitivity analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Study design.

    Study design. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 177
    Odds ratios for each case period compared with the control period.

    Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 178
    Sensitivity analysis of the group who had an exacerbation before the index date.

    Sensitivity analysis of the group who had an exacerbation before the index date. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 179
    Initial post-switch visits and SABA prescriptions in each period.

    Initial post-switch visits and SABA prescriptions in each period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 180
    Flow of eligible patients.

    Flow of eligible patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: